It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CVS’s FA Score shows that 3 FA rating(s) are green whileELV’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CVS’s TA Score shows that 5 TA indicator(s) are bullish while ELV’s TA Score has 4 bullish TA indicator(s).
CVS (@Publishing: Books/Magazines) experienced а +4.67% price change this week, while ELV (@Publishing: Books/Magazines) price change was +5.30% for the same time period.
The average weekly price growth across all stocks in the @Publishing: Books/Magazines industry was +4.60%. For the same industry, the average monthly price growth was -0.03%, and the average quarterly price growth was -10.10%.
CVS is expected to report earnings on Oct 29, 2025.
ELV is expected to report earnings on Oct 15, 2025.
The industry includes companies that publish and market books and magazines/periodicals. John Wiley & Sons, Inc., Meredith Corporation and Scholastic Corporation are some of the biggest companies in this industry. Like many other industries, publishing companies have branched out into online/digital publications (while retaining their original print business), to capture the burgeoning market in electronic media. Business could be cyclical in certain cases, since weak consumer sentiment during an economic downturn might depress sales of some magazines and books.
CVS | ELV | CVS / ELV | |
Capitalization | 87B | 69.7B | 125% |
EBITDA | 14.2B | N/A | - |
Gain YTD | 58.061 | -15.360 | -378% |
P/E Ratio | 19.11 | 13.13 | 145% |
Revenue | 387B | 189B | 205% |
Total Cash | 14.2B | 33.9B | 42% |
Total Debt | 82.7B | 30.2B | 274% |
CVS | ELV | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 14 | 7 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 16 Undervalued | 28 Undervalued | |
PROFIT vs RISK RATING 1..100 | 78 | 81 | |
SMR RATING 1..100 | 80 | 99 | |
PRICE GROWTH RATING 1..100 | 29 | 65 | |
P/E GROWTH RATING 1..100 | 11 | 86 | |
SEASONALITY SCORE 1..100 | 50 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CVS's Valuation (16) in the Drugstore Chains industry is in the same range as ELV (28) in the Managed Health Care industry. This means that CVS’s stock grew similarly to ELV’s over the last 12 months.
CVS's Profit vs Risk Rating (78) in the Drugstore Chains industry is in the same range as ELV (81) in the Managed Health Care industry. This means that CVS’s stock grew similarly to ELV’s over the last 12 months.
CVS's SMR Rating (80) in the Drugstore Chains industry is in the same range as ELV (99) in the Managed Health Care industry. This means that CVS’s stock grew similarly to ELV’s over the last 12 months.
CVS's Price Growth Rating (29) in the Drugstore Chains industry is somewhat better than the same rating for ELV (65) in the Managed Health Care industry. This means that CVS’s stock grew somewhat faster than ELV’s over the last 12 months.
CVS's P/E Growth Rating (11) in the Drugstore Chains industry is significantly better than the same rating for ELV (86) in the Managed Health Care industry. This means that CVS’s stock grew significantly faster than ELV’s over the last 12 months.
CVS | ELV | |
---|---|---|
RSI ODDS (%) | 1 day ago53% | 1 day ago58% |
Stochastic ODDS (%) | 1 day ago62% | 1 day ago58% |
Momentum ODDS (%) | 1 day ago66% | 1 day ago65% |
MACD ODDS (%) | 1 day ago60% | 1 day ago58% |
TrendWeek ODDS (%) | 1 day ago60% | 1 day ago56% |
TrendMonth ODDS (%) | 1 day ago57% | 1 day ago53% |
Advances ODDS (%) | 1 day ago63% | 1 day ago55% |
Declines ODDS (%) | 30 days ago58% | 16 days ago56% |
BollingerBands ODDS (%) | 1 day ago60% | 1 day ago59% |
Aroon ODDS (%) | 1 day ago58% | 1 day ago48% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
COPP | 23.39 | 0.16 | +0.69% |
Sprott Copper Miners ETF | |||
ISHG | 75.87 | 0.33 | +0.44% |
iShares 1-3 Year International TrsBd ETF | |||
SPRE | 19.22 | 0.07 | +0.37% |
SP Funds S&P Global REIT Sharia ETF | |||
SPAB | 25.51 | -0.04 | -0.16% |
SPDR® Portfolio Aggregate Bond ETF | |||
RDTE | 33.33 | -0.14 | -0.42% |
Roundhill Russell 2000 0DTECovCllStgyETF |
A.I.dvisor indicates that over the last year, CVS has been loosely correlated with CNC. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CVS jumps, then CNC could also see price increases.